Evidence map›Paper›PMID 22355113›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration.

M Kasim Diril, Chandrahas Koumar Ratnacaram, V C Padmakumar, Tiehua Du, Martin Wasser, Vincenzo Coppola, Lino Tessarollo, Philipp Kaldis

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 250 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
250citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

250 citing papers in PubMed, 1 synthesis or guideline pooled it, 401 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. CDC7 and APC/CNature communications · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. CMGC Kinases in Viral Infection and Human Disease.Pathogens (Basel, Switzerland) · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in cell and developmental biology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

190 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

M Kasim DirilInstitute of Molecular and Cell Biology, Agency for Science, Technology, and Research (ASTAR), Republic of Singapore 138673.
Chandrahas Koumar Ratnacaram
V C Padmakumar
Tiehua Du
Martin Wasser
Vincenzo Coppola
Lino Tessarollo
Philipp Kaldis
Agency for Science, Technology and Research · SGCancer Genetics (United States) · USInstitute of Molecular and Cell Biology · SGNational Cancer Institute · USNational University of Singapore · SG

Funding

Gene Targeting FacilityZICBC011265 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TESSAROLLO, LINO · 2010 to 2025
$8.9M
6 · The paper itself

Abstract

Cyclin-dependent kinase 1 (Cdk1) is an archetypical kinase and a central regulator that drives cells through G2 phase and mitosis. Knockouts of Cdk2, Cdk3, Cdk4, or Cdk6 have resulted in viable mice, but the in vivo functions of Cdk1 have not been fully explored in mammals. Here we have generated a conditional-knockout mouse model to study the functions of Cdk1 in vivo. Ablation of Cdk1 leads to arrest of embryonic development around the blastocyst stage. Interestingly, liver-specific deletion of Cdk1 is well tolerated, and liver regeneration after partial hepatectomy is not impaired, indicating that regeneration can be driven by cell growth without cell division. The loss of Cdk1 does not affect S phase progression but results in DNA re-replication because of an increase in Cdk2/cyclin A2 activity. Unlike other Cdks, loss of Cdk1 in the liver confers complete resistance against tumorigenesis induced by activated Ras and silencing of p53.

Indexed as

Liver RegenerationAnimalsBlastocystCDC2 Protein KinaseCell CycleCell DivisionDNA ReplicationGene Expression Regulation, NeoplasticGene SilencingGenes, p53Genes, rasMiceMice, KnockoutMitosisPolyploidyras ProteinsCDC2 Protein Kinaseras ProteinsTumor Suppressor Protein p53

Identifiers

PMID22355113
PMCPMC3309725
OpenAlexW2079019214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.